CN104666816A - 一种治疗视网膜动脉阻塞的中药制剂 - Google Patents
一种治疗视网膜动脉阻塞的中药制剂 Download PDFInfo
- Publication number
- CN104666816A CN104666816A CN201510074240.0A CN201510074240A CN104666816A CN 104666816 A CN104666816 A CN 104666816A CN 201510074240 A CN201510074240 A CN 201510074240A CN 104666816 A CN104666816 A CN 104666816A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- chinese medicine
- medicine preparation
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 230000002207 retinal effect Effects 0.000 title abstract description 5
- 208000021328 arterial occlusion Diseases 0.000 title abstract 2
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 22
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 201000007527 Retinal artery occlusion Diseases 0.000 claims description 17
- 239000009636 Huang Qi Substances 0.000 claims description 14
- 241000237903 Hirudo Species 0.000 claims description 11
- 210000000582 semen Anatomy 0.000 claims description 11
- 241000628997 Flos Species 0.000 claims description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 8
- 208000002193 Pain Diseases 0.000 abstract description 7
- 210000004185 liver Anatomy 0.000 abstract description 7
- 230000036407 pain Effects 0.000 abstract description 7
- 208000004880 Polyuria Diseases 0.000 abstract description 4
- 230000035619 diuresis Effects 0.000 abstract description 4
- 208000002173 dizziness Diseases 0.000 abstract description 4
- 201000010183 Papilledema Diseases 0.000 abstract description 3
- 206010038886 Retinal oedema Diseases 0.000 abstract description 3
- 201000011195 retinal edema Diseases 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 235000007516 Chrysanthemum Nutrition 0.000 abstract description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 2
- 206010022437 insomnia Diseases 0.000 abstract description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 abstract 1
- 206010000060 Abdominal distension Diseases 0.000 abstract 1
- 240000000031 Achyranthes bidentata Species 0.000 abstract 1
- 244000291564 Allium cepa Species 0.000 abstract 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000185686 Apocynum venetum Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241001080798 Polygala tenuifolia Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000157373 Uncaria rhynchophylla Species 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 30
- 239000008280 blood Substances 0.000 description 29
- 210000004369 blood Anatomy 0.000 description 29
- 230000004438 eyesight Effects 0.000 description 23
- 230000001737 promoting effect Effects 0.000 description 11
- 238000009835 boiling Methods 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 9
- 210000001367 artery Anatomy 0.000 description 8
- 210000001525 retina Anatomy 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 4
- 210000001747 pupil Anatomy 0.000 description 4
- 230000011514 reflex Effects 0.000 description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 3
- 239000002220 antihypertensive agent Substances 0.000 description 3
- 229940127088 antihypertensive drug Drugs 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000028867 ischemia Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000004446 light reflex Effects 0.000 description 3
- 210000002445 nipple Anatomy 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 229910052718 tin Inorganic materials 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- 208000019838 Blood disease Diseases 0.000 description 2
- 241000167854 Bourreria succulenta Species 0.000 description 2
- 206010033546 Pallor Diseases 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 2
- 208000002367 Retinal Perforations Diseases 0.000 description 2
- 206010038897 Retinal tear Diseases 0.000 description 2
- 101710104507 Retinochrome Proteins 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 235000019693 cherries Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 208000021245 head disease Diseases 0.000 description 2
- 208000014951 hematologic disease Diseases 0.000 description 2
- 208000018706 hematopoietic system disease Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 210000002189 macula lutea Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 210000004127 vitreous body Anatomy 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 108010027612 Batroxobin Proteins 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 229960003116 amyl nitrite Drugs 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 210000002159 anterior chamber Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000004453 corneal transparency Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 229960002768 dipyridamole Drugs 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 210000003017 ductus arteriosus Anatomy 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- CSDTZUBPSYWZDX-UHFFFAOYSA-N n-pentyl nitrite Chemical compound CCCCCON=O CSDTZUBPSYWZDX-UHFFFAOYSA-N 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 210000001636 ophthalmic artery Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 208000004644 retinal vein occlusion Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510074240.0A CN104666816A (zh) | 2015-02-12 | 2015-02-12 | 一种治疗视网膜动脉阻塞的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510074240.0A CN104666816A (zh) | 2015-02-12 | 2015-02-12 | 一种治疗视网膜动脉阻塞的中药制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104666816A true CN104666816A (zh) | 2015-06-03 |
Family
ID=53302752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510074240.0A Pending CN104666816A (zh) | 2015-02-12 | 2015-02-12 | 一种治疗视网膜动脉阻塞的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104666816A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1436549A (zh) * | 2002-02-07 | 2003-08-20 | 黄海波 | 一种中药复方三七滴丸及其制备方法 |
CN103860764A (zh) * | 2014-03-12 | 2014-06-18 | 逄增容 | 一种用于治疗视网膜中央动脉阻塞的中药及其制备方法 |
-
2015
- 2015-02-12 CN CN201510074240.0A patent/CN104666816A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1436549A (zh) * | 2002-02-07 | 2003-08-20 | 黄海波 | 一种中药复方三七滴丸及其制备方法 |
CN103860764A (zh) * | 2014-03-12 | 2014-06-18 | 逄增容 | 一种用于治疗视网膜中央动脉阻塞的中药及其制备方法 |
Non-Patent Citations (2)
Title |
---|
张明亮: "辨证为主治疗视网膜中央动脉阻塞3例", 《中国中医眼科杂志》 * |
王海燕等: "视网膜中央动脉阻塞的中医药治疗现状", 《江西中医药》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102579918B (zh) | 治疗青光眼的中药组合物、制备方法及给药方式 | |
CN102631558B (zh) | 一种用于治疗眼疾的中成药及其制备方法 | |
CN102600386B (zh) | 一种治疗眼科炎症的中药制剂及其制备方法 | |
CN105168984A (zh) | 一种治疗眼科疾病的中医复方视力贴 | |
CN103083546B (zh) | 障眼复明浓缩丸的加工方法 | |
CN102302740B (zh) | 一种治疗心肾阴虚型胸痹的中药制备方法 | |
CN105288208A (zh) | 一种治疗急性视神经炎的中药组合物 | |
CN105125630A (zh) | 一种眼药水及制备方法 | |
CN102755549B (zh) | 一种治疗白内障的药物及其制备方法 | |
CN106362089A (zh) | 一种治疗眼科疾病的外用药物 | |
CN104523981A (zh) | 一种治疗视神经炎的中药制剂及制备方法 | |
CN104666816A (zh) | 一种治疗视网膜动脉阻塞的中药制剂 | |
CN100421720C (zh) | 治疗乳痈的中药 | |
CN101537087B (zh) | 一种治疗视网膜静脉阻塞的中药组合物 | |
CN104306546A (zh) | 一种用于治疗视神经萎缩的中药组合物及其汤剂、丸剂和散剂 | |
CN102225105B (zh) | 一种治疗偏头痛的药物 | |
CN103908627A (zh) | 治疗视网膜中央静脉阻塞的中药制剂 | |
CN103550455B (zh) | 一种治疗青光眼的中药 | |
CN106491730A (zh) | 一种治疗青光眼的中药组合物及其制备方法 | |
CN105148118B (zh) | 一种治疗干眼症的中药组合物药剂及其制备方法 | |
CN105055764A (zh) | 一种用于治疗慢性闭角型青光眼的药物 | |
CN104524036A (zh) | 一种治疗视神经炎的中药制剂及制备方法 | |
CN104771638A (zh) | 用于治疗视神经萎缩的中药组合物 | |
CN104491476A (zh) | 治疗阴虚燥热型糖尿病性视网膜病变的药物及其制备方法 | |
CN102940706A (zh) | 一种治疗眼底出血的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Yang Bo Inventor before: Zhang Hongguo |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171031 Address after: 252000 the Yellow River road in Shandong province Liaocheng City Development Zone No. 16 Chong Building 3 unit 1601 room Applicant after: Yang Bo Address before: 252000 Shandong City, Liaocheng province Dongchangfu district culture Road 1 City Hospital of traditional Chinese medicine ophthalmology Applicant before: Zhang Hongguo |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150603 |
|
RJ01 | Rejection of invention patent application after publication |